WAUWATOSA, WI — Scientists from the University of Wisconsin-Milwaukee, the Medical College of Wisconsin (MCW) and Children''s Hospital of Wisconsin received a one-year, $20,000 grant to study the use of blue light as a possible therapy for methicillin-resistant Staphylococcus aureus (MRSA) infections, according to the Wauwatosa Now.
Emerging evidence may suggest that certain wavelengths of blue light kill MRSA, the article stated.
According to the article, the goals of this study are to optimize the bacteria-killing effect of blue light on MRSA either with or without hyperbaric oxygen, and to determine a therapeutic protocol for human MRSA cases.
This is one of 19 pilot projects being funded in 2012 through the Clinical and Translational Science Institute of Southeast Wisconsin (CTSI), whose goal is to create synergy through collaboration, and studies are specifically designed to lead to major future research support, the article noted.
Click here to read the complete article.